Nevada adopts NAC 453.510 Schedule I additions: ethylphenidate and 2‑methyl AP‑237 (R204-24)

Nevada State Board of Pharmacy adoption documentation (R204-24) indicates NAC 453.510 (Schedule I) was amended to add ethylphenidate and 2‑methyl AP‑237 to Nevada’s Schedule I list, as part of maintaining conformity with controlled-substance scheduling under Nevada’s Uniform Controlled Substances Act framework. Compliance impact: regulated Nevada handlers must update controlled-substance controls (inventory, access, procurement, analytical standards, and related compliance documentation) to reflect Schedule I status for these substances under state law.